SEC 13F Intelligence

Birchview Capital, LP / HTD

Birchview Capital, LP’s Corcept Therapeutics Inc Position

Does Birchview Capital, LP own Corcept Therapeutics Inc (HTD)? Yes — 47.2K shares worth $2M (+1.08% of its 13F portfolio) as of Q1 2026, down from 67.2K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
47.2K
% of Portfolio
+1.08%
Quarters Held
30
currently held

Position History HTD

Reported value by quarter
Q4 ’18: $668,000Q4 ’18Q1 ’19: $587,000Q2 ’19: $558,000Q3 ’19: $707,000Q4 ’19: $605,000Q4 ’19Q1 ’20: $594,000Q2 ’20: $841,000Q3 ’20: $870,000Q4 ’20: $1MQ4 ’20Q1 ’21: $1MQ2 ’21: $1MQ3 ’21: $984,000Q4 ’21: $990,000Q4 ’21Q1 ’22: $1MQ2 ’22: $1MQ3 ’22: $1MQ4 ’22: $1,016Q4 ’22Q1 ’23: $1,083Q2 ’23: $1MQ3 ’23: $1MQ4 ’23: $2MQ4 ’23Q1 ’24: $1MQ2 ’24: $2MQ3 ’24: $3MQ4 ’24: $4MQ4 ’24Q1 ’25: $8MQ2 ’25: $5MQ3 ’25: $6MQ4 ’25: $2MQ4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202647.2K$2M+1.08%
Q4 202567.2K$2M+1.37%
Q3 202567.2K$6M+4.22%
Q2 202567.2K$5M+4.90%
Q1 202566.0K$8M+6.55%
Q4 202474.0K$4M+3.04%
Q3 202474.0K$3M+2.97%
Q2 202474.0K$2M+2.23%
Q1 202450.0K$1M+1.03%
Q4 202350.0K$2M+1.27%
Q3 202350.0K$1M+1.16%
Q2 202350.0K$1M+0.83%
Q1 202350.0K$1,083+0.85%
Q4 202250.0K$1,016+0.72%
Q3 202250.0K$1M+0.90%
Q2 202250.0K$1M+0.86%
Q1 202250.0K$1M+0.81%
Q4 202150.0K$990,000+0.64%
Q3 202150.0K$984,000+0.67%
Q2 202150.0K$1M+0.66%
Q1 202150.0K$1M+0.71%
Q4 202050.0K$1M+0.75%
Q3 202050.0K$870,000+0.58%
Q2 202050.0K$841,000+0.51%
Q1 202050.0K$594,000+0.53%
Q4 201950.0K$605,000+0.44%
Q3 201950.0K$707,000+0.47%
Q2 201950.0K$558,000+0.34%
Q1 201950.0K$587,000+0.37%
Q4 201850.0K$668,000+0.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of HTD.